| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 37.635 | 28.683 | 17.768 | 35.374 | 41.101 | 37.773 | 31.661 | 12.793 | 7.057 | 3.152 |
| Total Income - EUR | 37.707 | 28.683 | 17.768 | 35.374 | 41.101 | 37.773 | 31.661 | 12.813 | 7.057 | 3.152 |
| Total Expenses - EUR | 37.912 | 20.495 | 9.555 | 16.040 | 25.736 | 20.643 | 18.489 | 12.148 | 8.433 | 3.929 |
| Gross Profit/Loss - EUR | -205 | 8.189 | 8.213 | 19.334 | 15.365 | 17.131 | 13.173 | 666 | -1.376 | -778 |
| Net Profit/Loss - EUR | -1.336 | 7.818 | 8.035 | 18.374 | 14.132 | 16.065 | 12.242 | 281 | -1.376 | -778 |
| Employees | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Transabo Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 337 | 249 | 161 | 75 | 0 | 0 | 520 | 281 | 40 | 0 |
| Current Assets | 13.556 | 9.642 | 16.407 | 24.214 | 36.694 | 49.956 | 55.850 | 41.105 | 35.194 | 33.858 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 687 | 0 | 0 |
| Receivables | 9.105 | 3.340 | 11.712 | 18.262 | 13.072 | 9.452 | 7.137 | 7.148 | 18.652 | 22.395 |
| Cash | 4.451 | 6.302 | 4.695 | 5.952 | 23.622 | 40.504 | 48.713 | 33.270 | 16.543 | 11.463 |
| Shareholders Funds | -21.366 | -13.331 | -5.070 | 13.397 | 27.270 | 42.818 | 49.854 | 39.618 | 33.068 | 32.105 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 35.259 | 23.221 | 21.638 | 10.892 | 9.424 | 7.138 | 6.515 | 1.768 | 2.167 | 1.753 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Transabo Med S.r.l.